Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in S. aureus Strains Including MRSA.

IF 1.9 4区 医学 Q3 CHEMISTRY, MEDICINAL
Peter Werner, David Kreutzer, Nikoletta Szemeredi, Gabriella Spengler, Andreas Hilgeroth
{"title":"Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in <i>S. aureus</i> Strains Including MRSA.","authors":"Peter Werner, David Kreutzer, Nikoletta Szemeredi, Gabriella Spengler, Andreas Hilgeroth","doi":"10.2174/0115734064302048240424045239","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The increasing antibacterial drug resistance remains a threat to global health with increasing mortality and morbidity. There is an urgent need to find novel antibacterials and develop alternative strategies to combat the increasing antibacterial drug resistance.</p><p><strong>Objective: </strong>We aimed to synthesize novel small-molecule antibacterials to evaluate the structuredependent antibacterial compound activities against S. aureus and MRSA.</p><p><strong>Methods: </strong>Compounds were synthesized by primary N-alkylation to form alkyl acridinium salts that were further functionalized with substituted phenyl residues and finally purified by column chromatography. The antibacterial growth inhibition activity was determined as MIC value.</p><p><strong>Results: </strong>The substituent effects on the determined antibacterial growth inhibitory properties have been discussed.</p><p><strong>Conclusion: </strong>The best activities have been found for compounds with methoxy functions, exceeding the activities of reported novel antibacterial peptides. The compounds have also shown antibacterial drug-enhancing effects, which have been manifested as a reduction in the MIC values of the used antibiotics.</p>","PeriodicalId":18382,"journal":{"name":"Medicinal Chemistry","volume":" ","pages":"831-838"},"PeriodicalIF":1.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734064302048240424045239","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The increasing antibacterial drug resistance remains a threat to global health with increasing mortality and morbidity. There is an urgent need to find novel antibacterials and develop alternative strategies to combat the increasing antibacterial drug resistance.

Objective: We aimed to synthesize novel small-molecule antibacterials to evaluate the structuredependent antibacterial compound activities against S. aureus and MRSA.

Methods: Compounds were synthesized by primary N-alkylation to form alkyl acridinium salts that were further functionalized with substituted phenyl residues and finally purified by column chromatography. The antibacterial growth inhibition activity was determined as MIC value.

Results: The substituent effects on the determined antibacterial growth inhibitory properties have been discussed.

Conclusion: The best activities have been found for compounds with methoxy functions, exceeding the activities of reported novel antibacterial peptides. The compounds have also shown antibacterial drug-enhancing effects, which have been manifested as a reduction in the MIC values of the used antibiotics.

在包括 MRSA 在内的金黄色葡萄球菌菌株中合成和评估具有还原吖啶结构的新型小分子抗菌剂。
背景:随着死亡率和发病率的上升,抗菌药物耐药性的不断增加仍然威胁着全球健康。目前迫切需要寻找新型抗菌药物并开发替代策略,以应对日益增长的抗菌药耐药性。 我们的目标是我们旨在合成新型小分子抗菌剂,以评估其对金黄色葡萄球菌和 MRSA 的结构依赖性抗菌化合物活性。 方法:通过一级 N-烷基化合成烷基吖啶鎓盐,再用取代的苯基残基进一步官能化,最后通过柱层析纯化。以 MIC 值确定抗菌生长抑制活性。 结果讨论了取代基对所测定的抗菌生长抑制特性的影响。 结论:发现具有甲氧基功能的化合物具有最好的活性,超过了已报道的新型抗菌肽的活性。这些化合物还显示出抗菌药物增强效应,表现为降低了所用抗生素的 MIC 值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicinal Chemistry
Medicinal Chemistry 医学-医药化学
CiteScore
4.30
自引率
4.30%
发文量
109
审稿时长
12 months
期刊介绍: Aims & Scope Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信